Literature DB >> 4201499

B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.

K J Gajl-Peczalska, J A Hansen, C D Bloomfield, R A Good.   

Abstract

B and T lymphocytes in 37 untreated patients with malignant lymphoma and Hodgkin's disease were studied. B cells in the peripheral blood were investigated with respect to surface immunoglobulins and in a few patients with respect to intracytoplasmic immunoglobulins by means of immunofluorescence. T cell function was studied by direct phytohemagglutinin (PHA) microtest (from the same sample of whole blood), mixed lymphocyte culture (MLC), and by delayed hypersensitivity to various antigens. In the 13 patients with Hodgkin's disease the histologic subtype was nodular sclerosis in nine, lymphocyte predominant in two, mixed cellularity in two. Only one of these patients had disseminated disease (stage IV); he showed impaired cellular immunity, a very low percentage of B cells and low levels of serum immunoglobulins. Of the remaining patients with Hodgkin's disease, with one exception, normal percentages but rather low absolute numbers of B lymphocytes per mm(3) of blood were found. One patient with a low percent and low absolute number of B lymphocytes showed very high serum IgG. Of 24 patients with non-Hodgkin's malignant lymphoma, seven (29%) showed monoclonal B cell proliferation in the peripheral blood (five mukappa, two gammakappa). By morphologic criteria, 14 patients had involvement of bone marrow, five of these had involvement of peripheral blood. Four of the latter five patients showed marked increases in percentages and absolute numbers of B lymphocytes in the peripheral blood reflecting the monoclonal proliferation. In three additional patients monoclonal proliferation of lymphocytes was found by immunofluorescence although the blood smears appeared morphologically normal. Serum immunoglobulin abnormalities without monoclonal B cell proliferation in the peripheral blood were observed in six patients.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4201499      PMCID: PMC302581          DOI: 10.1172/JCI107505

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Immunoglobulins on the surface of lymphocytes. 3. Bursal origin of surface immunoglobulins on chicken lymphocytes.

Authors:  E Rabellino; H M Grey
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

2.  Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia.

Authors:  J D Wilson; G J Nossal
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

3.  Restriction of surface immunoglobulin determinants to lymphocytes of the plasma cell line.

Authors:  P W Kincade; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

4.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

5.  Intracellular transport and secretion of an immunoglobulin light chain.

Authors:  Y S Choi; P M Knopf; E S Lennox
Journal:  Biochemistry       Date:  1971-02-16       Impact factor: 3.162

6.  Monoclonal macroglobulinemia in malignant lymphoma.

Authors:  D F Moore; P J Migliore; C C Shullenberger; R Alexanian
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

7.  Thymus-marrow cell combinations. Synergism in antibody production.

Authors:  H N Claman; E A Chaperon; R F Triplett
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

8.  Benign lymphoepithelial lesion of the lacrimal gland and its relationship to Sjögren's syndrome.

Authors:  R L Font; M Yanoff; L E Zimmerman
Journal:  Am J Clin Pathol       Date:  1967-10       Impact factor: 2.493

9.  Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin.

Authors:  E R Unanue; H M Grey; E Rabellino; P Campbell; J Schmidtke
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  Immunoglobulin spots on the surface of rabbit lymphocytes.

Authors:  B Pernis; L Forni; L Amante
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  14 in total

1.  B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors:  K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  T and B lymphocytes in humans. A review.

Authors:  J H Kersey; J Gajl-Peczalska
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

3.  Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

Authors:  Z Fuks; S Strober; A M Bobrove; T Sasazuki; A McMichael; H S Kaplan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

4.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Studies on blood lymphocytes of patients with nodular poorly differentiated lymphocytic lymphoma.

Authors:  A S Krajewski; A E Dewar
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

6.  B-cell markers on lymphoblasts in acute lymphoblastic leukaemia.

Authors:  K J Gajl-Peczalska; C D Bloomfield; M E Nesbit; J H Kersey
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

7.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

8.  E1Lymphocytopenia in pseudo-lupus-erythmetaosus syndrome.

Authors:  E Genth; W Hartl; H Hannig; E Steffens
Journal:  Blut       Date:  1976-10

9.  Immunocompetent cells in malignant disease in man. II. Clinical and immunologic correlates in a case of non-Hodgkin's lymphoma.

Authors:  D Algom; E Rapp; H Hamdy; M A Keaney; W Hirte; D J Klaassen; M Richter
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

10.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.